TLX News: Telix 2022 Full Year Results: Revenue up 20x in first year of commercial sales, underpins transition - 27th Feb 2023, 5:37pm

[annb0t]

MELBOURNE, Australia, Feb. 27, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the financial year ended 31 December 2022. All figures are in AU$ unless otherwise stated. (PRNewsfoto/Telix Pharmaceuticals Limited)

2022 HIGHLIGHTS

Total Group revenue $160.1M (2021: $7.6M) commercial launch of Illuccix® drives 20x increase in revenue Highly positive top-line data from Phase III ZIRCON trial of investigational kidney...

>>> Read more: Telix 2022 Full Year Results: Revenue up 20x in first year of commercial sales, underpins transition to cash flow positive